|
Transplant Statistics: Annual Report : Reference Tables
| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | ||
| Transplants | 12 | 22 | 34 | 23 | 46 | 45 | 68 | 69 | 71 | 79 | |
| Tx With Follow-up Immunosuppression Info | 0 | 0 | 6 | 14 | 28 | 28 | 35 | 38 | 33 | 47 | |
| Corticosteroids | Category Usage | 0.0% | 0.0% | 100.0% | 92.9% | 92.9% | 100.0% | 94.3% | 97.4% | 100.0% | 100.0% |
| Prednisone | 0.0% | 0.0% | 100.0% | 78.6% | 71.4% | 85.7% | 77.1% | 78.9% | 66.7% | 76.6% | |
| Methylprednisolone | 0.0% | 0.0% | 0.0% | 14.3% | 25.0% | 14.3% | 17.1% | 18.4% | 39.4% | 23.4% | |
| Cyclosporine | Category Usage | 0.0% | 0.0% | 33.3% | 21.4% | 10.7% | 10.7% | 5.7% | 2.6% | 3.0% | 0.0% |
| Cyclosporin | 0.0% | 0.0% | 33.3% | 21.4% | 7.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Sandimmmune | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 3.0% | 0.0% | |
| Neoral | 0.0% | 0.0% | 0.0% | 0.0% | 3.6% | 10.7% | 5.7% | 2.6% | 0.0% | 0.0% | |
| Tacrolimus | Category Usage | 0.0% | 0.0% | 83.3% | 85.7% | 92.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| FK506 | 0.0% | 0.0% | 83.3% | 85.7% | 92.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Antimetabolites | Category Usage | 0.0% | 0.0% | 33.3% | 14.3% | 39.3% | 67.9% | 34.3% | 31.6% | 33.3% | 14.9% |
| Azathioprine | 0.0% | 0.0% | 33.3% | 14.3% | 28.6% | 25.0% | 17.1% | 5.3% | 21.2% | 2.1% | |
| Mycophenolate mofetil | 0.0% | 0.0% | 0.0% | 0.0% | 25.0% | 57.1% | 22.9% | 26.3% | 21.2% | 12.8% | |
| Other | Category Usage | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 21.2% | 70.2% |
| Rapamycin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 21.2% | 70.2% | |
| Cytoxan | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.